In vitro senescence of rat mesenchymal stem cells is accompanied by downregulation of stemness-related and DNA damage repair genes

Stem Cells and Development

Volumn 18, Issue 7, 2009, Pages 1033-1041

  Galderisi, Umberto ^a,b,c   Helmbold, Heike ^d   Squillaro, Tiziana ^e   Alessio, Nicola ^a,c   Komm, Natascha ^d   Khadang, Baharak ^e   Cipollaro, Marilena ^a   Bohn, Wolfgang ^d   Giordano, Antonio ^b,c,e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b TEMPLE UNIVERSITY   (United States)

^c Human Health Foundation   (Italy)

^d LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^e UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; PROTEIN P107; PROTEIN P130; PROTEIN P53; PROTEIN RETINOBLASTOMA 1; PROTEIN RETINOBLASTOMA 2; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL AGING; CELL GROWTH; CELL PROLIFERATION; CELL RENEWAL; CELL THERAPY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; IN VITRO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BETA-GALACTOSIDASE; BIOLOGICAL MARKERS; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; DOWN-REGULATION; MALE; MESENCHYMAL STEM CELLS; RATS; RATS, INBRED WKY; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETINOBLASTOMA-LIKE PROTEIN P130; TELOMERASE;

ANIMALIA; RATTUS;

EID: 70349423739     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0324     Document Type: Article

References (44)

1. Campisi J and F d'Adda di Fagagna. (2007). Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8:729-740.
2. Sharpless NE and RA DePinho. (2007). How stem cells age and why this makes us grow old. Nat Rev Mol Cell Biol 8:703-713.
3. Beyer Nardi N and L da Silva Meirelles. (2006). Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 174:249-282.
4. Bianco P, M Riminucci, S Gronthos, and P Gehron Robey. (2001). Bone marrow stromal stem cells: nature, biology and potential applications. Stem Cells 19:180-192.
5. Muller-Sieburg CE and E Deryugina. (1995). The stromal cells' guide to the stem cell universe. Stem Cells 13:477-486.
6. Bianco P and P Gehron Robey. (2000). Marrow stromal stem cells. J Clin Invest 105:1663-1668.
7. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
8. Sethe S, A Scutt, and A Stolzing. (2006). Aging of mesenchymal stem cells. Ageing Res Rev 5:91-116.
9. Colter DC, R Class, CM DiGirolamo, and DJ Prockop. (2000). Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 97:3213-3218.
10. Kim NW, MA Piatyszek, KR Prowse, CB Harley, MD West, PL Ho, GM Coviello, WE Wright, SL Weinrich, and JW Shay. (1994). Specifi c association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
11. Kim NW and F Wu. (1997). Advances in quantifi cation and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 25:2595-2597.
12. Galderisi U, G Di Bernardo, M Cipollaro, G Peluso, A Cascino, R Cotrufo, and MA Melone. (1999). Differentiation and apoptosis of neuroblastoma cells: role of N-myc gene product. J Cell Biochem 73:97-105.
13. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop, and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
14. Forte A, M Finicelli, M Mattia, L Berrino, F Rossi, M De Feo, M Cotrufo, M Cipollaro, A Cascino, and U Galderisi. (2008). Mesenchymal stem cells effectively reduce surgically induced stenosis in rat carotids. J Cell Physiol 217:789-799.
15. Cai J, ML Weiss, and MS Rao. (2004). In search of "stemness." Exp Hematol 32:585-598.
16. Mikkers H and J Frisén. (2005). Deconstructing stemness. EMBO J 24:2715-2719.
17. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defined factors. Cell 126:663-676.
18. Ramalho-Santos M, S Yoon, Y Matsuzaki, RC Mulligan, and DA Melton."(2002). Stemness": transcriptional profiling of embryonic and adult stem cells. Science 298:597-600.
19. Meshorer E and T Misteli. (2006). Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol 7:540-546. (Pubitemid 44036459)
20. Miyamoto T and K Akashi. (2005). Lineage promiscuous expression of transcription factors in normal hematopoiesis. Int J Hematol 81:361-367.
21. Seshi B, S Kumar, and D King. (2003). Multilineage gene expression in human bone marrow stromal cells as evidenced by sin-gle-cell microarray analysis. Blood Cells Mol Dis 31:268-285.
22. Zipori D. (2004). Mesenchymal stem cells: harnessing cell plasticity to tissue and organ repair. Blood Cells Mol Dis 33:211-215.
23. Jori FP, MA Napolitano, MA Melone, M Cipollaro, A Cascino, A Giordano, and U Galderisi. (2004). Role of RB and RB2/P130 genes in marrow stromal stem cells plasticity. J Cell Physiol 200:201-212.
24. Hoeijmakers JH. (2001). Genome maintenance mechanisms for preventing cancer. Nature 411:366-374.
25. Khanna KK and SP Jackson. (2001). DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27:247-254.
26. Ronen A and BW Glickman. (2001). Human DNA repair genes. Environ Mol Mutagen 37:241-283.
27. Gage FH. (2000). Mammalian neural stem cells. Science 287:1433-1438.
28. Temple S. (2001). The development of neural stem cells. Nature 414:112-117.
29. Galderisi U, M Cipollaro, and A Giordano. (2006). The retinoblastoma gene is involved in multiple aspects of stem cell biology. Oncogene 25:5250-5256.
30. Oberdoerffer P and DA Sinclair. (2007). The role of nuclear architecture in genomic instability and ageing. Nat Rev Mol Cell Biol 8:692-702.
31. Giaccia AJ and MB Kastan. (1998). The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12:2973-2983.
32. Jackson JG and OM Pereira-Smith. (2006). Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-induced senescence of breast cancer cells. Mol Cell Biol 26:2501-2510.
33. Di Bernardo G, T Squillaro, C Dell'aversana, M Miceli, M Cipollaro, A Cascino, L Altucci, and U Galderisi. (2008). Histone Deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. Stem Cells Dev [Epub ahead of print].
34. Squillaro T, G Hayek, E Farina, M Cipollaro, A Renieri, and U Galderisi. (2008). A case report: bone marrow mesenchymal stem cells from a Rett syndrome patient are prone to senescence and show a lower degree of apoptosis. J Cell Biochem 103:1877-1885.
35. Ulloa-Montoya F, BL Kidder, KA Pauwelyn, LG Chase, A Luttun, A Crabbe, M Geraerts, AA Sharov, Y Piao, MS Ko, WS Hu, and CM Verfaillie. (2007). Comparative transcriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol 8:R163.
36. van den Boom V, SM Kooistra, M Boesjes, B Geverts, AB Houtsmuller, K Monzen, I Komuro, J Essers, LJ Drenth-Diephuis, and BJ Eggen. (2007). UTF1 is a chromatin-associated protein involved in ES cell differentiation. J Cell Biol 178:913-924.
37. Wagner W, P Horn, M Castoldi, A Diehlmann, S Bork, R Saffrich, V Benes, J Blake, S Pfister, V Eckstein, and AD Ho. (2008). Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE 3:e2213.
38. Serrano M and MA Blasco. (2007). Cancer and ageing: convergent and divergent mechanisms. Nat Rev Mol Cell Biol 8:715-722.
39. Shibata KR, T Aoyama, Y Shima, K Fukiage, S Otsuka, M Furu, Y Kohno, K Ito, S Fujibayashi, M Neo, T Nakayama, T Nakamura, and J Toguchida. (2007). Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 25:2371-2382.
40. Jiang Y, BN Jahagirdar, RL Reinhardt, RE Schwartz, CD Keene, XR Ortiz-Gonzalez, M Reyes, T Lenvik, T Lund, M Blackstad, J Du, S Aldrich, A Lisberg, WC Low, DA Largaespada, and CM Verfaillie. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41-49.
41. Agrawal S, ML Agarwal, M Chatterjee-Kishore, GR Stark, and GM Chisolm. (2002). Stat1-dependent, p53-independent expression of p21(waf1) modulates oxysterol-induced apoptosis. Mol Cell Biol 22:1981-1992.
42. Huo JX, SA Metz, and GD Li. (2004). p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion- induced apoptosis of insulin-secreting cells. Cell Death Differ 11:99-109.
43. Takagaki N, Y Sowa, T Oki, R Nakanishi, S Yogosawa, and T Sakai. (2005). Apigenin induces cell cycle arrest and p21/ WAF 1 expression in a p53-independent pathway. Int J Oncol 26:185-189.
44. Kapic A, H Helmbold, R Reimer, O Klotzsche, W Deppert, and W Bohn. (2006). Cooperation between p53 and p130(Rb2) in induction of cellular senescence. Cell Death Differ 13:324-334.